in

GC Rieber unveils new $75 million plant for sustainable omega-3 production

Completed two years earlier than estimated, the $75 million project will allow it to cater to the growing demand for sustainable, traceable, high-quality omega-3s.

The manufacturing facility fully aligns with the EU Green Deal initiatives and the UN Global Compact guidelines and makes GC Rieber VivoMega one of the world’s largest fish and algae manufacturing and storage facilities.

The facility includes: a 38,000 metric ton storage tank park, an electric steam boiler, additional heating capabilities to help maintain the quality of the oils and allow for easier extraction in winter, and additional nitrogen to remove oxygen for improved sensory profiles.

By transforming the energy source from fossil fuels to electricity produced by clean Norwegian hydropower, the electric steam boiler will enable its three facilities to run on 100% renewable energy.

Ståle Søfting, sales and marketing director at GC Rieber VivoMega, explained that the new storage capacity could help with price volatility in the future, the importance of.

which was discussed during the GOED Exchange earlier this year.

“The 38,000 metric tons tank park allows us to store raw materials for longer periods and supports our customers with flexible supply solutions to fit their needs,” he told NutraIngredients. “One example from previous periods of fish oil supply constraints is to limit our customers’ exposure to price volatility.”

According to GOED’s May 2024 Finished Product Report, EPA/DHA finished product sales of supplements grew by 9.1% in 2023. And demand for sustainable sources is growing with the GOED+Mintel report “Global Trends in EPA & DHA Supplement Product Introductions” reporting that claims related to a product’s environmental impact or the company’s environmental stewardship increased at least 10% from 2018 to 2023.

What do you think?

Written by The Muscle Mag

Is one dose of creatine supplementation suitable for everyone?

Danone boosts precision fermentation research and development in new biotech accelerator